Apricus Biosciences Inc (APRI) Stock News

USA - Nasdaq - NASDAQ:APRI -

0.22

-0.01 (-4.35%)

Last: 1/23/2019, 8:00:00 PM

0.24

+0.02 (+9.09%)

After Hours: 1/23/2019, 8:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

APRI Latest News, Press Relases and Analysis

All

Press Releases

2 years ago - By: Seeking Alpha - Mentions: ROSS

Alzheimer's-focused Aprinoia Therapeutics sets terms for $24M IPO (Pending:APRI)

7 years ago - By: Benzinga - Mentions: XBI AMGN ARNA IBB ...

The Daily Biotech Pulse: Intuitive Surgical Earnings, Corbus To Offer Shares, Eton In-Licenses Neurologic Drug

7 years ago - By: Benzinga - Mentions: XBI ACHN ALKS AMGN ...

The Daily Biotech Pulse: Pfizer-Glaxo Set Up Consumer Health Care Venture, New Patent For Adamas

8 years ago - By: Active-Investors - Mentions: CRME

News Image

Blog Exposure - Cipher to Acquire Cardiome’s Canadian Business Portfolio for $25.5 Million in Cash

8 years ago - By: Investor Network

News Image

Apricus Biosciences, Inc. to Host Earnings Call

8 years ago - By: Smarter Analyst

Apricus Biosciences (APRI) Shares Fell Off: What You Need to Know

8 years ago - By: Traders News Source

News Image

Apricus Biosciences, Vitaros Update, The ED Market, Analysts Target Price, Pipeline

8 years ago - By: Smarter Analyst

Apricus Biosciences Inc (APRI) Loses a Bull After ED Cream Gets Hit with Problematic CRL

8 years ago - By: Smarter Analyst

Is It “Game Over” After Apricus Biosciences Inc (APRI) FDA Rejection?